missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Human/Mouse NLRP3/NALP3 Antibody, R&D Systems™

Descripción
NLRP3/NALP3 Monoclonal specifically detects NLRP3/NALP3 in Human, Mouse samples. It is validated for Western Blot, Immunohistochemistry, Intracellular Staining by Flow Cytometry, Immunocytochemistry, CyTOF-ready.
Especificaciones
Especificaciones
| Antígeno | NLRP3/NALP3 |
| Aplicaciones | Western Blot, Immunohistochemistry, Flow Cytometry, Immunocytochemistry, CyTOF |
| Clasificación | Monoclonal |
| Clon | 768319 |
| Concentración | LYOPH |
| Conjugado | Unconjugated |
| Dilución | Western Blot 2 μg/mL, Immunohistochemistry 5-25 μg/mL, Intracellular Staining by Flow Cytometry 2.5 μg/10^6 cells, Immunocytochemistry 8-25 μg/mL, CyTOF-ready |
| Formulación | Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative |
| N.º de referencia del gen | Q8R4B8 |
| Alias de gen | AGTAVPRL, AII, AII/AVP, Angiotensin/vasopressin receptor AII/AVP-like, AVP, C1orf7, Caterpiller protein 1.1, CIAS1, CLR1.1, Cold autoinflammatory syndrome 1, Cold autoinflammatory syndrome 1 protein, Cryopyrin, Familial cold autoinflammatory syndrome, FCAS, FCU, Leucine-rich repeat-, and PYD-containing protein 3, Muckle-Wells syndrome, MWS, NACHT, NACHT, LRR and PYD containing protein 3, NACHT, LRR and PYD domains-containing protein 3, NALP3, NLR family, pyrin domain containing 3, NLRP3, Nucleotide-Binding Oligomerization Domain, Leucine Rich Repeat And Pyrin Domain Containing 3, PYPAF1, PYRIN-containing APAF1-like protein 1 |
| Mostrar más |
For Research Use Only
Título del producto
Al hacer clic en Enviar, acepta que Fisher Scientific se ponga en contacto con usted en relación con los comentarios que ha proporcionado en este formulario. No compartiremos su información para ningún otro fin. Toda la información de contacto proporcionada se mantendrá de acuerdo con nuestra Política de Privacidad. Política de privacidad.
¿Detecta una oportunidad de mejora?